| | Home > News & Events > 2013 Press Releases | 2013 Press Releases | Receive Email Alerts | | To receive the latest news on INC Research, sign up now to receive email alerts every time new company information is posted. |
 |
|
 | INC Research Leads Conversation on Clinical Innovation at DIA 2013 Annual Meeting
June 19, 2013| Global CRO Explores Role of Innovation in Clinical Research, Offers Strategies to Reduce Costs and Development Time Raleigh, N.C., June 19, 2013 - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will be showcasing the latest advances in clinical trial innovation with an extensive presence at the DIA 2013 Annual Meeting from June 23-27 at the Boston Convention and Exhibition Center. In addition to partic... |
| | | INC Research Releases New White Paper on How Clinical Innovation Leads to Improved Predictability and Efficiency for Drug Development Programs
June 18, 2013| Paper offers innovative approaches to bringing drugs to market faster and reducing development costs Raleigh, N.C., June 18, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it has released a new white paper titled, "Clinical Process Innovations for New Drug Development: Aligning Clinical Trials with Development Needs." INC Research's paper explores the challenges bio... |
| | | INC Research Named "Best CRO" at the Triangle Business Journal Life Sciences Awards
June 13, 2013| Global CRO recognized for "breaking new ground" in life sciences research
Raleigh, N.C., June 13, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, has been named "Best CRO" at the inaugural Triangle Business Journal Life Sciences Awards. The awards recognize both individuals and research organizations that are breaking new ground in the life sciences field. INC Research accepted th... |
| | | INC Research, LLC Second Quarter 2013 Results of Operations Release Date and Conference Call
June 06, 2013| Raleigh, N.C., June 6, 2013 - INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will conduct a conference call to discuss its second quarter 2013 financial results at 10:00 a.m. ET on Tuesday, August 13, 2013. The second quarter financial results will be available on the Company's secure website no later than August 12, 2013. To access the financial results and dial-in information ... |
| | | INC Research Promotes Medical and Oncology Expertise in Support of "Building Bridges to Conquer Cancer" Initiative at 2013 ASCO Annual Meeting
May 31, 2013| Global CRO Offers Specialist Teams for Oncology Drug Development Raleigh, N.C., May 31, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, is attending the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 - June 4 in Chicago to discuss accelerating development in the quest to conquer cancer."We are excited to be taking part once again in this year's ASCO and its ... |
| | | INC Research Announces 2013 "Perspectives" Webinar Series
May 15, 2013| Series Offers Industry-Leading Insights into Key Issues in Clinical DevelopmentRaleigh, N.C., May 15, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it will kick off its 2013 "Perspectives" webinar series June 18 with a session focused on clinical innovation. Designed to provide the latest insights on clinical research, the eight-session series will feature industry... |
| | | INC Research Rated "Top CRO" by Investigative Sites Globally
May 01, 2013| Company achieves top overall ranking in 2013 CenterWatch Global Investigative Site Relationship Survey, receiving the highest "excellent" scores in six out of seven working relationship categories among all CROs included in the surveyRaleigh, N.C., May 1, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, is ranked the "Top CRO" in the 2013 CenterWatch Global Investigative Si... |
| | | INC Research CEO & COO Participate in Partnerships in Clinical Trials 2013
April 22, 2013| Global CRO's executive leaders offer insights in managing outsourcing risk and optimizing data in clinical development Raleigh, N.C., Apr. 22, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced CEO Jamie Macdonald and COO Alistair Macdonald will participate in key panel discussions at this year's Partnerships in Clinical Trials conference, April 21-24, 2013, in Orlando, Florida. ... |
| | | INC Research, LLC First Quarter 2013 Results of Operations Release Date and Conference Call
April 01, 2013| Raleigh, N.C., April 1, 2013 - INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will conduct a conference call to discuss its first quarter 2013 financial results at 10:00 a.m. ET on Tuesday, May 14, 2013. The first quarter financial results will be available on the Company's secure website no later than May 13, 2013. To access the financial results and dial-in information for the... |
| | | INC Research Appoints James Taylor Vice President, Clinical Development
March 11, 2013| 25-year veteran of the life sciences industry brings extensive large pharma experience encompassing CRO oversight, project management and operational deliveryRaleigh, N.C., March 11, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced James Taylor has joined the Company as Vice President, Clinical Development. Mr. Taylor joins INC Research from Pfizer, where he served most recentl... |
| | | INC Research to Present at DIA’s 25th Annual EuroMeeting
March 04, 2013| Global CRO Offers Clinical, Regulatory and Post Approval Expertise for Conducting Trials in Europe
Raleigh, NC, Mar. 4, 2013 – INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced that it will be showcasing its regional development strategies and regulatory expertise at DIA’s 25th Annual EuroMeeting in Amsterdam, March 4-6. The Company’s thought leaders are participating in three educati... |
| | | INC Research Names Garth Tierney Executive Vice President, Asia/Pacific
February 27, 2013| Tierney brings more than 25 years of experience in the region to key leadership role; succeeds Kelvin Logan, PhD, who is retiring following 11 years with the Company Raleigh, N.C., and Port Adelaide, South Australia, Feb. 27, 2013 - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the promotion of Garth Tierney to Executive Vice President, Asia/Pacific responsible for driving the strate... |
| | | INC Research, LLC Fourth Quarter 2012 Results of Operations Release Date and Conference Call
February 08, 2013| Raleigh, N.C., Feb. 8, 2013 - INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will conduct a conference call to discuss its fourth quarter 2012 financial results at 10:00 a.m. ET on Thursday, March 28, 2013. The fourth quarter financial results will be available on the Company's secure website no later than March 27, 2013. To access the financial results and dial-in informati... |
| | | INC Research Partners with goBalto™ to Further Enhance Clinical Study Startup Solution
January 08, 2013| Will Use goBalto Tracker Platform to Optimize Site Activation and Increase Efficiencies in Study Startup
SAN FRANCISCO, Jan. 8, 2013 /PRNewswire/ -- goBalto, Inc., a developer of new-generation web clinical research solutions, today announced that INC Research, a therapeutically-focused clinical research organization (CRO), has selected goBalto Tracker 2.0 as its global site activation solution. Tracker is a secure, web-based platform that enables study teams to track and manage site activation... |
| | | Jamie Macdonald Assumes CEO Role at INC Research; Succession Plan Complete
January 07, 2013| Raleigh, N.C., Jan. 7, 2013 - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today reported the completion of its CEO succession plan announced in August 2012. Effective Jan. 1, 2013, Jamie Macdonald, formerly Chief Operating Officer for the Company, officially assumed the role of INC Research's new Chief Executive Officer. Mr. Macdonald replaced James T. Ogle, who remains with the Company as Chairm... |
| |
|
| |
|
|
|
